UNSPSC 51183104: Benfluorex hydrochloride

This classification denotes an anti-lipidemic agent and anorexiant with the molecular formula C19H20F3NO2.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier X7O165XZ00, chemically known as phenethylamine, n-(2-hydroxyethyl)-alpha-methyl-m-trifluoromethyl-, benzoate but more generally known as benfluorex hydrochloride, which bears US NIH Compound Identifier 2318. European Medicines Agency schedules Benfluorex hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00701MIG.

Most nations, for tariff and trade purposes, schedule benfluorex hydrochloride under HS 29221980 and SITC 51461. As of Q4 2014, BENFLUOREX HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. SMILES: CC(CC1CCCC(C1)C(F)(F)F)NCCOC(=O)C2CCCCC2.CL.

UNSPSC 51183104 Benfluorex hydrochloride, a Commodity code, identifies a pharmaceutical active ingredient used in state and local procurement activity related to medical supplies and therapeutic agents. State and local governments procure benfluorex hydrochloride primarily through health departments, correctional facilities, public health clinics, and hospital systems that stock formulary medications and manage chronic disease treatments. The compound appears in solicitations for bulk pharmaceutical inventory, compounded medications, and therapeutic supply contracts where dosage forms and purity specifications drive purchasing requirements.

The source provided contains no recent state and local contract opportunities tagged to this code, making it difficult to characterize current issuing-body patterns, geographic concentration, or representative active solicitations. Without posted RFP, RFQ, IFB, or ITB records, activity under this Commodity code cannot be assessed for decision-making purposes at this time.